• Keine Ergebnisse gefunden

Alternative approach for recombinant protein expression in the mammary gland

Expression of active fluorophore proteins in the milk of transgenic pigs bypassing the secretory pathway

9.3 Alternative approach for recombinant protein expression in the mammary gland

Mammary gland of transgenic animals as a bioreactor has been extensively exploited to produce recombinant proteins at large scale. In case of human lactoferrin, a yield of grams per litre has been achieved (van Berkel et al., 2002;

Yang et al., 2008; Goldman et al., 2012), but in some experiments only minute amounts of recombinant protein were obtained (Platenburg et al., 1994;

Niemann et al., 1999; Tong et al., 2011). To achieve high expression of recombinant proteins in the milk of transgenic animals, a secretory signal sequence along with a mammary gland-specific promoter element, like those of the casein, lacto-globulin and lacto-albumin genes are commonly used (Whitelaw et al., 2016).

Here, I describe an alternative approach to produce recombinant proteins in the mammary gland. In this study, reporter transposon pig lines carrying the Venus, or the mCherry constructs (see 9.2) were exploited. The reporter constructs were driven by the ubiquitously active CAGGS promoter, and devoid of a signal peptide sequence, resulting in robust expression and a cytoplasmic localisation of Venus and mCherry fluorophores (Mukherjee et al., submitted).

However, high levels of Venus and mCherry proteins were readily detected in sow milk samples from the two lines, respectively. For the Venus fluorophore an expression level of 0.27 – 0.38 g/l, and for mCherry an expression level of 0.2 – 0.25 g/l were determined. Considering that porcine milk contains 6–8 g of protein

61

per litre (Klobasa et al., 1987), this equals to 2.5 – 6.3 % of the total protein content (Mukherjee et al., submitted).

The cumulative data suggested that the recombinant Venus and mCherry are not transported via the secretory pathway, but that exfoliated cells of the udder epithelium carried Venus or mCherry into the milk. During lactation, the udder epithelium represents one of the most highly proliferative tissues in mammals (Chepko and Smith, 1997), and undergoes substantial remodelling (Strange et al., 1992). The somatic cell count of porcine milk is higher than in other mammals, and has been determined between 108 to 1010 cells per litre (Magnusson et al., 1991; Scharek-Tedin et al., 2015). The milk cells represent apoptotic cells, but also vital lactocytes (milk secretory cells), epithelial and immune cells (Hassiotou and Hartmann, 2014). The colostrum typically contains a relatively high number of immune cells, which declines in mature milk. In healthy sows after the first week of lactation, the vast majority (>95%) of milk cells consist of lactocytes and mammary myoepithelial cells (Scharek-Tedin et al., 2015).

The expression analysis of blood fractions suggested minute or un-detectable levels of Venus and mCherry fluorophore in the blood serum.

Here, in this study an alternative approach of harvesting recombinant proteins in large scale through somatic cell fraction of milk has been described.

The data suggest that SB transposon-mediated gene delivery prefers transcriptionally permissive genomic loci. For the development of SB transposon based DNA vaccines, as well as the SB transposon based recombinant protein production, the targeting of transcriptionally permissive loci in the porcine genome is an important advantage. Thus the here established methods and findings provide the basis for more advanced approaches.

62

63

Acknowledgements

Being Doctor of Philosophy (PhD) is undoubtedly a great achievement. When I revisit last three year of my PhD research stay in Germany, I evaluate my achievements in regards of some other parameters, which provided me some extra satisfaction. Commencing the journey from a phase of lowest position of sinusoidal curve of my academic career, my PhD research stay repositioned me at the peak. These three years of most productive and intensive stage of my life was incubated with an excellent environment with dynamic minds, including both from the scientific community and outside of the academic environment. I am grateful to all those seen and unseen hands which pushed me forward towards the right path of knowledge, experience and enlightenment.

Leader is a person, who gives credits of an achievement, to its team members, always being behind the curtain. On this auspicious occasion, I would like to unveil that person to extend my sincere thanks to my ‘Guru’ in true sense, Dr. Wilfried August Kues, for his able guidance, appreciation, suggestions, constructive criticism, providing me knowledge to develop concepts, indefatigable encouragement from the inception of this project, giving critical comments wherever and whenever required, very worthy discussions, being counsellor and morale booster and providing fatherly affection and care during this period.

I offer a special thanks to Prof. Dr. Pablo Steinberg and Prof. Dr. Klaus Osterrieder, for their careful and professional guidance and constant encouragement. They have always been kind and helping. They always monitored the progress of my work and were available when I needed their advice.

64

I am also thankful to Prof. Dr. Heiner Niemann, Director, Institute of Farm Animal Genetics, FLI, Mariensee, for providing me the necessary research and academic facilities required for my study and research work.

I would like to convey my sincere gratitude to Indian Council of Agricultural Research (ICAR) for the financial support throughout my research stay and constant monitoring of the progress of my research.

Shiddhartha Da, Sujoy Da, Aishik and Debasmita – as I don’t have any word to express my gratitude for their critical supports, I just want to say ‘thank you’ for their affection and truthfulness and moral support during all the lows of my life.

I would also like to express my gratitude for sincere efforts of Maren, Sabine, Doris, Patrik, Karin and Tony for their help, patience, support and valuable suggestions with all their expertise to make my research endeavour to a success.

Without friends life would have been a monochromic canvas. I am feeling privileged to thanks all those wavelengths that illuminated my canvas with rainbow. I am truly thankful to the almighty for having friends like Roberto, Sandra, Rao sir, Dharmendra sir, Rolf, Diego. I specifically feel blessed to have friend like Roberto. I just want to say “Thank you”, for all those adventures. I am equally thankful to Dorothee, Amanda, Jun, Ilka, Ronja …….. for their constant efforts to make my life happening.

It will be injustice if I don’t express my thanks to all those public bicycles which have taken all the pains to carry me to the every corner of the nearby swamp areas.

My life has been always embellished with the blessing, love and uninterrupted support from my parents Mr. Bijan Mukherjee, Mrs. Dhira Mukherjee and my sis Jayanti Mukherjee whose sustained encouragement and love always pushed me to achieve new heights. I also owe a lot to facebook, youtube, Whats App, Gmail and skype. It is their presence which brought my two

65

worlds together and it is their presence that didn’t allow me to feel the distance.

As there are not enough words to express my profound feeling of reverence and love for my family, I just wanted to say, I owe a lot to them.

And many others who are not mentioned, but no one is forgotten……

Finally, as though I am very small before him, still I would wish to acknowledge ‘God’ without whose blessing this small piece of work would have never been successful all through the way of truth and love and also creating such a beautiful world for us with all amenities.

Thank you all………

66

67 References

Ahrens, U., Kaden, V., Drexler, C., Visser, N., 2000. Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows. Vet Microbiol 77, 83-97.

Andrew, M., Morris, K., Coupar, B., Sproat, K., Oke, P., Bruce, M., Broadway, M., Morrissy, C., Strom, D., 2006. Porcine interleukin-3 enhances DNA vaccination against classical swine fever. Vaccine 24, 3241-3247.

Andrew, M.E., Morrissy, C.J., Lenghaus, C., Oke, P.G., Sproat, K.W., Hodgson, A.L., Johnson, M.A., Coupar, B.E., 2000. Protection of pigs against classical swine fever with DNA-delivered gp55.

Vaccine 18, 1932-1938.

Baus, J., Liu, L., Heggestad, A.D., Sanz, S., Fletcher, B.S., 2005. Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther 12, 1148-1156.

Beer, M., Reimann, I., Hoffmann, B., Depner, K., 2007. Novel marker vaccines against classical swine fever. Vaccine 25, 5665-5670.

Belak, K., Koenen, F., Vanderhallen, H., Mittelholzer, C., Feliziani, F., De Mia, G.M., Belak, S., 2008.

Comparative studies on the pathogenicity and tissue distribution of three virulence variants of classical swine fever virus, two field isolates and one vaccine strain, with special regard to immunohistochemical investigations. Acta Vet Scand 50, 34.

Bensaude, E., Turner, J.L., Wakeley, P.R., Sweetman, D.A., Pardieu, C., Drew, T.W., Wileman, T., Powell, P.P., 2004. Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells. J Gen Virol 85, 1029-1037.

Bintintan, I., Meyers, G., 2010. A new type of signal peptidase cleavage site identified in an RNA virus polyprotein. J Biol Chem 285, 8572-8584.

Blome, S., Meindl-Bohmer, A., Loeffen, W., Thuer, B., Moennig, V., 2006. Assessment of classical swine fever diagnostics and vaccine performance. Rev Sci Tech 25, 1025-1038.

Bosch, P., Forcato, D.O., Alustiza, F.E., Alessio, A.P., Fili, A.E., Olmos Nicotra, M.F., Liaudat, A.C., Rodriguez, N., Talluri, T.R., Kues, W.A., 2015. Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals. Cell Mol Life Sci 72, 1907-1929.

Bouma, A., De Smit, A.J., De Jong, M.C., De Kluijver, E.P., Moormann, R.J., 2000. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus.

Vaccine 18, 1374-1381.

Bruschke, C.J., Hulst, M.M., Moormann, R.J., van Rijn, P.A., van Oirschot, J.T., 1997. Glycoprotein Erns of pestiviruses induces apoptosis in lymphocytes of several species. J Virol 71, 6692-6696.

Bryan, G., Garza, D., Hartl, D., 1990. Insertion and excision of the transposable element mariner in Drosophila. Genetics 125, 103-114.

68

Chander, V., Nandi, S., Ravishankar, C., Upmanyu, V., Verma, R., 2014. Classical swine fever in pigs:

recent developments and future perspectives. Anim Health Res Rev 15, 87-101.

Chang, C.Y., Huang, C.C., Deng, M.C., Huang, Y.L., Lin, Y.J., Liu, H.M., Lin, Y.L., Wang, F.I., 2012a.

Antigenic mimicking with cysteine-based cyclized peptides reveals a previously unknown antigenic determinant on E2 glycoprotein of classical swine fever virus. Virus Res 163, 190-196.

Chang, C.Y., Huang, C.C., Deng, M.C., Huang, Y.L., Lin, Y.J., Liu, H.M., Lin, Y.L., Wang, F.I., 2012b.

Identification of conformational epitopes and antigen-specific residues at the D/A domains and the extramembrane C-terminal region of E2 glycoprotein of classical swine fever virus. Virus Res 168, 56-63.

Chang, C.Y., Huang, C.C., Lin, Y.J., Deng, M.C., Chen, H.C., Tsai, C.H., Chang, W.M., Wang, F.I., 2010.

Antigenic domains analysis of classical swine fever virus E2 glycoprotein by mutagenesis and conformation-dependent monoclonal antibodies. Virus Res 149, 183-189.

Chepko, G., Smith, G.H., 1997. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell. 29, 239-253.

Cheville, N.F., Mengeling, W.L., Zinober, M.R., 1970. Ultrastructural and immunofluorescent studies of glomerulonephritis in chronic hog cholera. Lab Invest 22, 458-467.

Choi, C., Hwang, K.K., Chae, C., 2004. Classical swine fever virus induces tumor necrosis factor-alpha and lymphocyte apoptosis. Arch Virol 149, 875-889.

de Smit, A.J., Bouma, A., de Kluijver, E.P., Terpstra, C., Moormann, R.J., 2000. Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine. Vet Q 22, 150-153.

Depner, K.R., Bouma, A., Koenen, F., Klinkenberg, D., Lange, E., de Smit, H., Vanderhallen, H., 2001.

Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows. Vet Microbiol 83, 107-120.

Dewulf, J., Laevens, H., Koenen, F., Mintiens, K., de Kruif, A., 2001. An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Vaccine 20, 86-91.

Dewulf, J., Laevens, H., Koenen, F., Mintiens, K., de Kruif, A., 2004. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.

Prev Vet Med 65, 121-133.

Ding, S., Wu, X., Li, G., Han, M., Zhuang, Y., Xu, T., 2005. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122, 473-483.

Dong, X.N., Chen, Y.H., 2006. Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2. Vaccine 24, 1906-1913.

Dong, X.N., Chen, Y.H., 2007. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25, 205-230.

Donnelly, J.J., Ulmer, J.B., Shiver, J.W., Liu, M.A., 1997. DNA vaccines. Annu Rev Immunol 15, 617-648.

69

Drager, C., Petrov, A., Beer, M., Teifke, J.P., Blome, S., 2015. Classical swine fever virus marker vaccine strain CP7_E2alf: Shedding and dissemination studies in boars. Vaccine 33, 3100-3103.

Edwards, S., Fukusho, A., Lefevre, P.C., Lipowski, A., Pejsak, Z., Roehe, P., Westergaard, J., 2000.

Classical swine fever: the global situation. Vet Microbiol 73, 103-119.

El Omari, K., Iourin, O., Harlos, K., Grimes, J.M., Stuart, D.I., 2013. Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry. Cell Rep 3, 30-35.

Everett, H., Crooke, H., Gurrala, R., Dwarka, R., Kim, J., Botha, B., Lubisi, A., Pardini, A., Gers, S., Vosloo, W., Drew, T., 2011. Experimental infection of common warthogs (Phacochoerus africanus) and bushpigs (Potamochoerus larvatus) with classical swine fever virus. I: Susceptibility and transmission. Transbound Emerg Dis 58, 128-134.

Fedoroff, N.V., 1989. zolt. Cell 56, 181-191.

Fernandez-Sainz, I.J., Largo, E., Gladue, D.P., Fletcher, P., O'Donnell, V., Holinka, L.G., Carey, L.B., Lu, X., Nieva, J.L., Borca, M.V., 2014. Effect of specific amino acid substitutions in the putative fusion peptide of structural glycoprotein E2 on Classical Swine Fever Virus replication. Virology 456-457, 121-130.

Fetzer, C., Tews, B.A., Meyers, G., 2005. The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor. J Virol 79, 11901-11913.

Fletcher, S.P., Ali, I.K., Kaminski, A., Digard, P., Jackson, R.J., 2002. The influence of viral coding sequences on pestivirus IRES activity reveals further parallels with translation initiation in prokaryotes. RNA 8, 1558-1571.

Franzoni, G., Kurkure, N.V., Edgar, D.S., Everett, H.E., Gerner, W., Bodman-Smith, K.B., Crooke, H.R., Graham, S.P., 2013. Assessment of the phenotype and functionality of porcine CD8 T cell responses following vaccination with live attenuated classical swine fever virus (CSFV) and virulent CSFV challenge. Clin Vaccine Immunol 20, 1604-1616.

Frey, C.F., Bauhofer, O., Ruggli, N., Summerfield, A., Hofmann, M.A., Tratschin, J.D., 2006. Classical and targeted integration in the pig genome. PLoS One 6, e23573.

Garrels, W., Mukherjee, A., Holler, S., Cleve, N., Talluri, T.R., Barg-Kues, B., Diederich, M., Kohler, P., Petersen, B., Lucas-Hahn, A., Niemann, H., Izsvak, Z., Ivics, Z., Kues, W.A., 2016. Identification and re-addressing of a transcriptionally permissive locus in the porcine genome. Transgenic Res 25, 63-70.

70

Gers, S., Vosloo, W., Drew, T., Lubisi, A.B., Pardini, A., Williams, M., 2011. Experimental infection of common warthogs (Phacochoerus africanus) and bushpigs (Potamochoerus larvatus) with classical swine fever virus II: A comparative histopathological study. Transbound Emerg Dis 58, 135-144.

Gladue, D.P., Baker-Bransetter, R., Holinka, L.G., Fernandez-Sainz, I.J., O'Donnell, V., Fletcher, P., Lu, Z., Borca, M.V., 2014. Interaction of CSFV E2 protein with swine host factors as detected by yeast two-hybrid system. PLoS One 9, e85324.

Goldman, I.L., Georgieva, S.G., Gurskiy, Y.G., Krasnov, A.N., Deykin, A.V., Popov, A.N., Ermolkevich, T.G., Budzevich, A.I., Chernousov, A.D., Sadchikova, E.R., 2012. Production of human lactoferrin in animal milk. Biochem Cell Biol. 90, 513-519.

Gottipati, K., Ruggli, N., Gerber, M., Tratschin, J.D., Benning, M., Bellamy, H., Choi, K.H., 2013. The structure of classical swine fever virus N(pro): a novel cysteine Autoprotease and zinc-binding protein involved in subversion of type I interferon induction. PLoS Pathog 9, e1003704.

Hahn, J., Park, S.H., Song, J.Y., An, S.H., Ahn, B.Y., 2001. Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein. J Virol Methods 93, 49-56.

Hammond, J.M., Jansen, E.S., Morrissy, C.J., Goff, W.V., Meehan, G.C., Williamson, M.M., Lenghaus, C., Sproat, K.W., Andrew, M.E., Coupar, B.E., Johnson, M.A., 2001. A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever. Vet Microbiol 80, 101-119.

Hammond, J.M., Johnson, M.A., 2005. Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics. Vet J 169, 17-27.

Hassiotou, F., Hartmann, P.E., 2014. At the dawn of a new discovery: the potential of breast milk stem cells. Adv Nutr. 5, 770-778.

Heimann, M., Roman-Sosa, G., Martoglio, B., Thiel, H.J., Rumenapf, T., 2006. Core protein of pestiviruses is processed at the C terminus by signal peptide peptidase. J Virol 80, 1915-1921.

Henke, A., 2002. DNA immunization--a new chance in vaccine research? Med Microbiol Immunol 191, 187-190.

Huang, X., Guo, H., Tammana, S., Jung, Y.C., Mellgren, E., Bassi, P., Cao, Q., Tu, Z.J., Kim, Y.C., Ekker, S.C., Wu, X., Wang, S.M., Zhou, X., 2010. Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 18, 1803-1813.

Huang, Y.L., Deng, M.C., Wang, F.I., Huang, C.C., Chang, C.Y., 2014. The challenges of classical swine fever control: modified live and E2 subunit vaccines. Virus Res 179, 1-11.

Hulst, M.M., Westra, D.F., Wensvoort, G., Moormann, R.J., 1993. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 67, 5435-5442.

Ivics, Z., Hackett, P.B., Plasterk, R.H., Izsvak, Z., 1997. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501-510.

Ivics, Z., Izsvak, Z., 2006. Transposons for gene therapy! Curr Gene Ther 6, 593-607.

71

Ivics, Z., Izsvak, Z., 2010. The expanding universe of transposon technologies for gene and cell engineering. Mob DNA 1, 25.

Izsvak, Z., Hackett, P.B., Cooper, L.J., Ivics, Z., 2010. Translating Sleeping Beauty transposition into cellular therapies: victories and challenges. Bioessays 32, 756-767.

Jakobsen, J.E., Johansen, M.G., Schmidt, M., Dagnaes-Hansen, F., Dam, K., Gunnarsson, A., Liu, Y., Kragh, P.M., Li, R., Holm, I.E., Callesen, H., Mikkelsen, J.G., Nielsen, A.L., Jorgensen, A.L., 2013.

Generation of minipigs with targeted transgene insertion by recombinase-mediated cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT). Transgenic Res 22, 709-723.

Ji, W., Guo, Z., Ding, N.Z., He, C.Q., 2015. Studying classical swine fever virus: making the best of a bad virus. Virus Res 197, 35-47.

Kaufman, P.D., Rio, D.C., 1992. P element transposition in vitro proceeds by a cut-and-paste mechanism and uses GTP as a cofactor. Cell 69, 27-39.

Klobasa, F., Werhahn, E., Butler, J.E., 1987. Composition of sow milk during lactation. J Anim Sci 64, 1458-1466.

Koga, A., Iida, A., Hori, H., Shimada, A., Shima, A., 2006. Vertebrate DNA transposon as a natural mutator: the medaka fish Tol2 element contributes to genetic variation without recognizable traces. Mol Biol Evol 23, 1414-1419.

Konig, M., Lengsfeld, T., Pauly, T., Stark, R., Thiel, H.J., 1995. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 69, 6479-6486.

Lecot, S., Belouzard, S., Dubuisson, J., Rouille, Y., 2005. Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis. J Virol 79, 10826-10829.

Li, G.X., Zhou, Y.J., Yu, H., Li, L., Wang, Y.X., Tong, W., Hou, J.W., Xu, Y.Z., Zhu, J.P., Xu, A.T., Tong, G.Z., 2012. A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits. Vet Microbiol 156, 200-204.

Li, X., Yang, Y., Bu, L., Guo, X., Tang, C., Song, J., Fan, N., Zhao, B., Ouyang, Z., Liu, Z., Zhao, Y., Yi, X., Quan, L., Liu, S., Yang, Z., Ouyang, H., Chen, Y.E., Wang, Z., Lai, L., 2014. Rosa26-targeted swine models for stable gene over-expression and Cre-mediated lineage tracing. Cell Res 24, 501-504.

Liu, S., Tu, C., Wang, C., Yu, X., Wu, J., Guo, S., Shao, M., Gong, Q., Zhu, Q., Kong, X., 2006a. The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2. J Virol Methods 134, 125-129.

Liu, S., Yu, X., Wang, C., Wu, J., Kong, X., Tu, C., 2006b. Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus. Vaccine 24, 7175-7180.

Magnusson, U., Rodriguez-Martinez, H., Einarsson, S., 1991. A simple, rapid method for differential cell counts in porcine mammary secretions. Vet Rec. 129, 485-490.

Markowska-Daniel, I., Collins, R.A., Pejsak, Z., 2001. Evaluation of genetic vaccine against classical swine fever. Vaccine 19, 2480-2484.

72

Mates, L., Chuah, M.K., Belay, E., Jerchow, B., Manoj, N., Acosta-Sanchez, A., Grzela, D.P., Schmitt, A., Becker, K., Matrai, J., Ma, L., Samara-Kuko, E., Gysemans, C., Pryputniewicz, D., Miskey, C., Fletcher, B., VandenDriessche, T., Ivics, Z., Izsvak, Z., 2009. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41, 753-761.

Maurer, R., Stettler, P., Ruggli, N., Hofmann, M.A., Tratschin, J.D., 2005. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Vaccine 23, 3318-3328.

McClintock, B., 1950. The origin and behavior of mutable loci in maize. Proc Natl Acad Sci U S A 36, 344-355.

Meyer, H., Liess, B., Frey, H.R., Hermanns, W., Trautwein, G., 1981. Experimental transplacental transmission of hog cholera virus in pigs. IV. Virological and serological studies in newborn piglets.

Zentralbl Veterinarmed B 28, 659-668.

Meyers, G., Thiel, H.J., 1996. Molecular characterization of pestiviruses. Adv Virus Res 47, 53-118.

Miousse, I.R., Chalbot, M.C., Lumen, A., Ferguson, A., Kavouras, I.G., Koturbash, I., 2015. Response of transposable elements to environmental stressors. Mutat Res Rev Mutat Res 765, 19-39.

Moldt, B., Miskey, C., Staunstrup, N.H., Gogol-Doring, A., Bak, R.O., Sharma, N., Mates, L., Izsvak, Z., Chen, W., Ivics, Z., Mikkelsen, J.G., 2011. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells. Mol Ther 19, 1499-1510.

Monso, M., Tarradas, J., de la Torre, B.G., Sobrino, F., Ganges, L., Andreu, D., 2011. Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes. J Pept Sci 17, 24-31.

Moormann, R.J., Bouma, A., Kramps, J.A., Terpstra, C., De Smit, H.J., 2000. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol 73, 209-219.

Morgan, T.H., 1922. Croonian Lecture: On the Mechanism of Heredity. Proceedings of the Royal Society of London B: Biological Sciences 94, 162-197.

Moulin, H.R., Seuberlich, T., Bauhofer, O., Bennett, L.C., Tratschin, J.D., Hofmann, M.A., Ruggli, N., 2007. Nonstructural proteins NS2-3 and NS4A of classical swine fever virus: essential features for infectious particle formation. Virology 365, 376-389.

Niemann, H., Halter, R., Carnwath, J.W., Herrmann, D., Lemme, E., Paul, D., 1999. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res. 8, 237-247.

Paton, D.J., McGoldrick, A., Greiser-Wilke, I., Parchariyanon, S., Song, J.Y., Liou, P.P., Stadejek, T., Lowings, J.P., Bjorklund, H., Belak, S., 2000. Genetic typing of classical swine fever virus. Vet Microbiol 73, 137-157.

73

Platenburg, G.J., Kootwijk, E.P., Kooiman, P.M., Woloshuk, S.L., Nuijens, J.H., Krimpenfort, P.J., Pieper, F.R., de Boer, H.A., Strijker, R., 1994. Expression of human lactoferrin in milk of transgenic mice.

Transgenic Res. 3, 99-108.

Qi, Y., Zhang, B.Q., Shen, Z., Chen, Y.H., 2009. Antigens containing TAVSPTTLR tandem repeats could be used in assaying antibodies to Classical swine fever virus. Acta Virol 53, 241-246.

Reimann, I., Depner, K., Trapp, S., Beer, M., 2004. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322, 143-157.

Reimann, I., Depner, K., Utke, K., Leifer, I., Lange, E., Beer, M., 2010. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Vet Microbiol 142, 45-50.

Reimann, I., Meyers, G., Beer, M., 2003. Trans-complementation of autonomously replicating Bovine viral diarrhea virus replicons with deletions in the E2 coding region. Virology 307, 213-227.

Rossi, S., Staubach, C., Blome, S., Guberti, V., Thulke, H.H., Vos, A., Koenen, F., Le Potier, M.F., 2015.

Controlling of CSFV in European wild boar using oral vaccination: a review. Front Microbiol 6,

Controlling of CSFV in European wild boar using oral vaccination: a review. Front Microbiol 6,